Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Showing 1-25 of 50 citing articles:

Hypoxia-inducible factors: master regulators of hypoxic tumor immune escape
Qinghua Wu, You Li, Eugenie Nepovimová, et al.
Journal of Hematology & Oncology (2022) Vol. 15, Iss. 1
Open Access | Times Cited: 261
Acquired IFNγ resistance impairs anti-tumor immunity and gives rise to T-cell-resistant melanoma lesions
Antje Sucker, Fang Zhao, Natalia Pieper, et al.
Nature Communications (2017) Vol. 8, Iss. 1
Open Access | Times Cited: 225
Roles of tumor-associated macrophages in anti-PD-1/PD-L1 immunotherapy for solid cancers
Hao Zhang, Lin Liu, Jinbo Liu, et al.
Molecular Cancer (2023) Vol. 22, Iss. 1
Open Access | Times Cited: 170
Rationale of combination of anti-PD-1/PD-L1 antibody therapy and radiotherapy for cancer treatment
Hiro Sato, Noriyuki Okonogi, Takashi Nakano
International Journal of Clinical Oncology (2020) Vol. 25, Iss. 5, pp. 801-809
Open Access | Times Cited: 148
Predicting response and toxicity to immune checkpoint inhibitors using routinely available blood and clinical markers
Ashley M. Hopkins, Andrew Rowland, Ganessan Kichenadasse, et al.
British Journal of Cancer (2017) Vol. 117, Iss. 7, pp. 913-920
Open Access | Times Cited: 163
Basis of PD1/PD-L1 Therapies
Barbara Seliger
Journal of Clinical Medicine (2019) Vol. 8, Iss. 12, pp. 2168-2168
Open Access | Times Cited: 101
The role of cancer stem cells in the modulation of anti-tumor immune responses
Cristina Maccalli, Kakil Ibrahim Rasul, Mamoun Elawad, et al.
Seminars in Cancer Biology (2018) Vol. 53, pp. 189-200
Open Access | Times Cited: 88
Tumor mutational burden for the prediction of PD-(L)1 blockade efficacy in cancer: challenges and opportunities
Xinan Wang, Giuseppe Lamberti, Alessandro Di Federico, et al.
Annals of Oncology (2024) Vol. 35, Iss. 6, pp. 508-522
Closed Access | Times Cited: 13
Immune microenvironment spatial landscapes of tertiary lymphoid structures in gastric cancer
Yi Xie, Haoxin Peng, Yajie Hu, et al.
BMC Medicine (2025) Vol. 23, Iss. 1
Open Access | Times Cited: 1
Tumor microenvironment: recent advances in understanding and its role in modulating cancer therapies
Disha D. Shah, Mehul R. Chorawala, Neha R. Raghani, et al.
Medical Oncology (2025) Vol. 42, Iss. 4
Closed Access | Times Cited: 1
HLA-G/ILTs Targeted Solid Cancer Immunotherapy: Opportunities and Challenges
Aifen Lin, Wei‐Hua Yan
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 47
Reversible epigenetic alterations regulate class I HLA loss in prostate cancer
Tamara S. Rodems, Erika Héninger, Charlotte N. Stahlfeld, et al.
Communications Biology (2022) Vol. 5, Iss. 1
Open Access | Times Cited: 33
Expression of classical human leukocyte antigen class I antigens, HLA‐E and HLA‐G, is adversely prognostic in pancreatic cancer patients
Nobuyoshi Hiraoka, Yoshinori Ino, Shutaro Hori, et al.
Cancer Science (2020) Vol. 111, Iss. 8, pp. 3057-3070
Open Access | Times Cited: 47
Targeting NK Cells to Enhance Melanoma Response to Immunotherapies
Hansol Lee, Inês Pires da Silva, Umaimainthan Palendira, et al.
Cancers (2021) Vol. 13, Iss. 6, pp. 1363-1363
Open Access | Times Cited: 36
EMT-induced immune evasion: connecting the dots from mechanisms to therapy
Sikiru O. Imodoye, Kamoru A. Adedokun
Clinical and Experimental Medicine (2023) Vol. 23, Iss. 8, pp. 4265-4287
Closed Access | Times Cited: 14
Pervasiveness of HLA allele-specific expression loss across tumor types
Ioan Filip, Anqi Wang, Oleksandr Valeriiovych Kravets, et al.
Genome Medicine (2023) Vol. 15, Iss. 1
Open Access | Times Cited: 12
Research progress on molecular mechanism of liver metastasis of gastric cancer and treatment with traditional Chinese medicine
Caiyue Liu, Zheng Li, F Cheng, et al.
Journal of Cancer (2025) Vol. 16, Iss. 6, pp. 1944-1957
Open Access
Immune evasion strategies in AFP-producing gastric carcinoma: characterized by HLA-G expression and HLA class I deficiency
Sho Yamazawa, Miyako Fukasawa-Hokazono, A. Takase, et al.
Virchows Archiv (2025)
Open Access
Influence of tumor-associated macrophages and HLA class I expression according to HPV status in head and neck cancer patients receiving chemo/bioradiotherapy
Dan Ou, Julien Adam, Ingrid Garberis, et al.
Radiotherapy and Oncology (2018) Vol. 130, pp. 89-96
Open Access | Times Cited: 28
Human leukocyte antigen class II expression is a good prognostic factor in adult T-cell leukemia/lymphoma
Mai Takeuchi, Hiroaki Miyoshi, Naoko Asano, et al.
Haematologica (2019) Vol. 104, Iss. 8, pp. 1626-1632
Open Access | Times Cited: 28
Identification of microRNAs Targeting the Transporter Associated with Antigen Processing TAP1 in Melanoma
Maria‐Filothei Lazaridou, Chiara Massa, Diana Handke, et al.
Journal of Clinical Medicine (2020) Vol. 9, Iss. 9, pp. 2690-2690
Open Access | Times Cited: 25
Immunogenic cell death triggered by impaired deubiquitination in multiple myeloma relies on dysregulated type I interferon signaling
Zeinab Waad Sadiq, Annamaria Brioli, Ruba Al‐Abdulla, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 8
Loss of HLA-class-I expression in non-small-cell lung cancer: Association with prognosis and anaerobic metabolism
Ioannis M. Koukourakis, Alexandra Giatromanolaki, Achilleas Mitrakas, et al.
Cellular Immunology (2022) Vol. 373, pp. 104495-104495
Closed Access | Times Cited: 12
A diversity of novel type-2 innate lymphoid cell subpopulations revealed during tumour expansion
Clara Wenjing Xia, Iryna Saranchova, Pablo L. Finkel, et al.
Communications Biology (2024) Vol. 7, Iss. 1
Open Access | Times Cited: 2
Tumor Microenvironment, HLA Class I and APM Expression in HPV-Negative Oral Squamous Cell Carcinoma
Claudia Wickenhauser, Daniel Bethmann, Matthias Kappler, et al.
Cancers (2021) Vol. 13, Iss. 4, pp. 620-620
Open Access | Times Cited: 15
Page 1 - Next Page

Scroll to top